What is Pivot Bio?
Founded in 2010 and headquartered in Berkeley, California, Pivot Bio operates at the intersection of biotechnology and sustainable farming. The company specializes in engineering microbes that naturally fix nitrogen from the atmosphere, providing a biological alternative to traditional, carbon-intensive synthetic fertilizers. By enhancing the plant microbiome, Pivot Bio enables farmers to improve crop yields while simultaneously reducing the environmental footprint of global agriculture.
The firm's market position is defined by its deep-tech approach to soil health and nutrient management. As global demand for sustainable food production intensifies, Pivot Bio's technology serves as a vital tool for decarbonizing the agricultural sector. Their platform is not merely a product but a scalable infrastructure for the future of farming, attracting interest from both climate-focused venture capital and traditional agribusiness conglomerates.
How much funding has Pivot Bio raised?
Pivot Bio has raised a total of $616.7M across 5 funding rounds:
Private Equity
$749K
Series A
$16M
Series B
$70M
Series C
$100M
Series D
$430M
Private Equity (2014): $749K, investors not publicly disclosed
Series A (2016): $16M, investors not publicly disclosed
Series B (2018): $70M supported by Breakthrough Energy Ventures and Temasek
Series C (2020): $100M featuring Bunge Ventures, CGC, Alan Cohen, Roger Underwood, Prelude Ventures, Breakthrough Energy Ventures, Temasek, Spruce Capital Partners, Tekfen Ventures, DCVC Management, Pavilion Capital, and Codon Capital
Series D (2021): $430M, investors not publicly disclosed
Key Investors in Pivot Bio
Breakthrough Energy Ventures
A climate-focused investment firm backed by global business leaders, dedicated to funding companies that can significantly reduce emissions across key sectors including agriculture.
Temasek
A Singapore-based global investment company that operates as a generational investor, focusing on long-term value creation and sustainable growth.
DCVC Management
A deep tech venture capital firm that leverages artificial intelligence and scientific innovation to solve complex challenges in biotechnology and agriculture.
What's next for Pivot Bio?
Looking ahead, the recent $430M injection provides Pivot Bio with the necessary runway to accelerate its commercial expansion and R&D initiatives. The company is expected to focus on scaling its manufacturing capabilities and broadening its product portfolio to address diverse crop types and geographic markets. As the firm matures, strategic priorities will likely shift toward deepening its integration within the global agricultural ecosystem and solidifying its leadership in the bio-fertilizer market.
The continued support from institutional investors suggests a long-term commitment to the company's vision of a net-zero agricultural future. By maintaining its focus on high-impact, science-led solutions, Pivot Bio is well-positioned to navigate the complexities of the global food system, potentially setting new standards for efficiency and sustainability in the industry.
